Summary

The smoke evacuation systems market is projected to reach USD 266.4 million by 2029 from USD 187.6 million in 2024, at a CAGR of 7.3% during the forecast period.
Minimally invasive procedures are witnessing a huge demand due to benefits such as quicker recovery, smaller incisions, fewer complications, and reduced hospitalisation periods. This is due to the fact that their patient base is increasing significantly in recent years. This growing demand is closely tied to lifestyle factors, such as lack of exercise and poor dieting, compounded by an ageing population, which explain the rise in chronic illnesses like arthritis and cardiovascular diseases.
The market is also driven by several other factors such as rise in technological advancements, rising R&D spending, increased awareness of dangers of surgical smoke, and expansion in economy of emerging countries.
“The smoke evacuation pencils & wands segment accounted for largest share of the smoke evacuation systems market during the forecast period.”
On the basis of product type, the smoke evacuation systems market is segmented into smoke evacuation systems, smoke evacuation filters, smoke evacuation pencils & wands, smoke-evac fusion products (shrouds), smoke evacuation tubings, and accessories. The smoke evacuation pencils & wands segment is estimated to account for the largest share during the forecast period due to it’s affordable pricing, wide variety affordable pricing, a variety of pencils suitable for various applications, and technological advancements enhancing their designs and smoke evacuation capabilities.
“The Laparoscopic surgeries segment accounted for the largest share, by application during the forecast period.
On the basis of applications, the smoke evacuation systems market is segmented into laparoscopic surgeries, general surgeries, orthopedic surgeries, and medical aesthetics surgeries
Laparoscopic surgeries accounted for largest share of the smoke evacuation systems market in 2023. Various conditions such as obesity, liver disease, pelvic infections, tubal ligation, kidney stones etc can be treated with Laparoscopic surgeries. This is due to the numerous factors such as being cost-effective, minimally invasive in nature and an elevated population of patients, advancement in technology around the world.
“North America accounted for the largest share, by region and APAC is estimated to register the highest CAGR during the forecast period.”
The smoke evacuation systems market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America had largest share in the smoke evacuation systems market for a number of key considerations. Its advanced healthcare system, compounded by a robust reimbursement system for multiple kind of surgeries, supports the deployment of advanced smoke evacuation systems for the population. Robust regulatory systems in the US facilitate the development and introduction of high-quality smoke evacuation systems, ensuring that these devices meet stringent safety and efficacy standards for optimal patient care. Also, the high disposable income of general population has contributed to strong demand for elective surgeries, including bariatric, cosmetic, and plastic procedures
The Asia Pacific is witnessed to have the highest CAGR during the forecast period. Many APAC countries, including Japan, South Korea, and China, are witnessing huge demand for plastic and cosmetic surgeries. Also, there is increased healthcare expenditure in rising economies such as India, Thailand and Malaysia. Also, the fast increasing ageing population in the region experience various chronic illnesses for which surgeries needs to be performed.
A breakdown of the primary participants (supply-side) for the Smoke Evacuation Systems market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
• By Designation: C-level–20%, Director Level–35%, and Others–45%
• By Region: North America–27%, Europe–25%, Asia Pacific–30%, Others- 18% .
The prominent players in the Smoke evacuation systems market are Conmed Corporation (US), Medtronic (Ireland), Stryker (US), Johnson & Johnson (USA), Olympus Corporation (Japan), Danaher Corporation (US), Ecolab (USA), Zimmer Biomet (USA), CooperCompanies (USA), Utah Medical Products (USA), DeRoyal Industries (USA), ERBE Elektromedizin GmbH (Germany), KLS Martin (Germany), I.C. Medical (USA), Aspen Surgical (US), BOWA-electronic GmbH & Co. KG (Germany), Karl Storz (Germany), Surgiform Technology (US), Alesi Surgical (UK), Meyer Haake (Germany), Steris (US), Cimpax A/S (Denmark), CLS Surgimedics (US), ATMOS MedizinTechnik GmbH & Co. KG (Germany) and Walker Filtration (USA).

Research Coverage
This report studies the Smoke Evacuation Systems Market based on products, applications, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Smoke Evacuation Systems Market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report
This report also includes.
• Analysis of key drivers (increased product availability, rising patient preference for minimally invasive surgeries), restraints (lack of uniform regulatory guidelines across the world regarding surgical smoke evacuation), challenges (surgeons’ resistance to adopt smoke evacuators), and opportunities (rising technological advancements) contributing to the growth of the Smoke Evacuation Systems Market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Smoke Evacuation Systems Market.
• Market Development: Comprehensive information on the lucrative emerging markets by products, applications, end-users and region.
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Smoke Evacuation Systems Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Smoke Evacuation Systems Market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION 36
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 37
1.4 STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 42
2.1.2.1 Key data from primary sources 43
2.1.2.2 Key industry insights 44
2.2 MARKET SIZE ESTIMATION 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 52
2.4 MARKET SHARE ESTIMATION 53
2.5 ASSUMPTIONS 53
2.6 LIMITATIONS 53
2.6.1 METHODOLOGY-RELATED LIMITATIONS 53
2.6.2 SCOPE-RELATED LIMITATIONS 54
2.7 RISK ASSESSMENT 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 59
4.1 SMOKE EVACUATION SYSTEMS MARKET OVERVIEW 59
4.2 ASIA PACIFIC: SMOKE EVACUATION SYSTEMS MARKET, BY END USER AND COUNTRY (2023) 60
4.3 SMOKE EVACUATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
4.4 SMOKE EVACUATION SYSTEMS MARKET, BY REGION (2024−2029) 62
4.5 SMOKE EVACUATION SYSTEMS MARKET: DEVELOPED VS. EMERGING MARKETS 62
 
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 64
5.2.1 DRIVERS 64
5.2.1.1 Increased product availability 64
5.2.1.2 Rising patient preference for minimally invasive surgeries 65
5.2.1.3 Growing target patient population 66
5.2.1.4 Wider acceptance and availability of relevant operating room protocols and guidelines 67
5.2.2 RESTRAINTS 68
5.2.2.1 Lack of uniform regulatory guidelines regarding surgical smoke evacuation 68
5.2.2.2 High cost associated with procurement and installation 69
5.2.3 OPPORTUNITIES 69
5.2.3.1 Emerging markets 69
5.2.3.2 Rising technological advancements 70
5.2.4 CHALLENGES 70
5.2.4.1 Resistance of surgeons to adopt smoke evacuators 70
5.2.4.2 Safety concerns regarding smoke evacuation systems 71
5.3 INDUSTRY TRENDS 71
5.3.1 ADVANCEMENTS IN DESIGN SMOKE EVACUATION PENCILS 71
5.3.2 COLLABORATIONS BETWEEN MANUFACTURERS AND ORGANIZATIONS TO RAISE AWARENESS 72
5.4 VALUE CHAIN ANALYSIS 72
5.5 TECHNOLOGY ANALYSIS 73
5.5.1 KEY TECHNOLOGIES 73
5.5.1.1 ULPA filters 73
5.5.1.2 Electrosurgical unit (ESU) pencils 74
5.5.2 COMPLEMENTARY TECHNOLOGIES 74
5.5.2.1 RF sensors 74
5.5.2.2 Smoke evacuation tubing 74
5.5.3 ADJACENT TECHNOLOGIES 74
5.5.3.1 Ultrasonic electrosurgery 74
5.6 PORTER’S FIVE FORCES ANALYSIS 75
5.6.1 THREAT OF NEW ENTRANTS 76
5.6.2 THREAT OF SUBSTITUTES 76
5.6.3 BARGAINING POWER OF SUPPLIERS 76
5.6.4 BARGAINING POWER OF BUYERS 77
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 77
 
5.7 REGULATORY ANALYSIS 78
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.7.2 REGULATORY LANDSCAPE 80
5.7.2.1 North America 80
5.7.2.1.1 US 80
5.7.2.1.2 Canada 81
5.7.2.2 Europe 81
5.7.2.3 Asia Pacific 81
5.7.2.3.1 Japan 81
5.7.2.3.2 China 82
5.7.2.3.3 India 83
5.7.2.4 Latin America 83
5.7.2.4.1 Brazil 83
5.7.2.4.2 Mexico 83
5.7.2.5 GCC Countries 84
5.8 PATENT ANALYSIS 84
5.8.1 PATENT PUBLICATION TRENDS FOR SMOKE EVACUATION SYSTEMS 84
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 84
5.8.3 TOP APPLICANT COUNTRIES/REGIONS PATENTS FOR SMOKE EVACUATION SYSTEM PATENTS (JANUARY 2014−NOVEMBER 2024) 86
5.9 TRADE ANALYSIS 88
5.9.1 IMPORT DATA 88
5.9.2 EXPORT DATA 88
5.10 PRICING ANALYSIS 89
5.10.1 AVERAGE SELLING PRICE TREND OF SMOKE EVACUATION SYSTEMS,
BY REGION 89
5.10.2 AVERAGE SELLING PRICE TREND OF SMOKE EVACUATION SYSTEMS,
BY COMPANY, 2023 89
5.11 KEY CONFERENCES & EVENTS, 2024–2025 90
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
5.12.2 BUYING CRITERIA 91
5.13 UNMET NEEDS/END-USER EXPECTATIONS 92
5.13.1 UNMET NEEDS 92
5.13.2 END-USER EXPECTATIONS 92
5.14 ADJACENT MARKET ANALYSIS 93
5.15 ECOSYSTEM ANALYSIS 93
5.16 CASE STUDY ANALYSIS 96
5.16.1 CASE STUDY 1: MASSACHUSETTS GENERAL HOSPITAL AIMS TO ACHIEVE 100% SMOKE-FREE STANDARD BY 2024 96
5.16.2 CASE STUDY 2: THE PIH HEALTH DOWNEY HOSPITAL HAS BEEN SMOKE-FREE FOR THE LAST THREE YEARS 96
5.16.3 CASE STUDY 3: THE DOERNBECHER CHILDREN’S HOSPITAL WON THE AORN GO CLEAR AWARD IN APRIL 2023 97
5.17 SUPPLY CHAIN ANALYSIS 97
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 98
5.19 INVESTMENT & FUNDING SCENARIO 99
5.20 REIMBURSEMENT SCENARIO 100
5.21 IMPACT OF AI/GEN AI ON SMOKE EVACUATION SYSTEMS MARKET 100
6 SMOKE EVACUATION SYSTEMS MARKET, BY PRODUCT 102
6.1 INTRODUCTION 103
6.2 SMOKE EVACUATION PENCILS & WANDS 104
6.2.1 INCREASING NUMBER OF ELECTROSURGERIES TO DRIVE MARKET 104
6.3 SMOKE EVACUATION FILTERS 107
6.3.1 ULTRALOW PENETRATION AIR FILTERS 110
6.3.1.1 High efficiency and longer running ability to fuel uptake 110
6.3.2 CHARCOAL FILTERS 113
6.3.2.1 Simplified usage for removal of toxins to drive market 113
6.3.3 IN-LINE FILTERS 116
6.3.3.1 Decreased efficiency with time to limit market growth 116
6.3.4 PRE-FILTERS 119
6.3.4.1 Low maintenance cost and long product life to boost demand 119
6.4 SMOKE EVACUATION SYSTEMS 122
6.4.1 STATIONARY SYSTEMS 126
6.4.1.1 One-time installation and minimal user maintenance to drive market 126
6.4.2 PORTABLE SYSTEMS 129
6.4.2.1 Convenient transportation and remote efficiency to fuel uptake 129
6.5 SMOKE EVACUATION FUSION PRODUCTS 132
6.5.1 INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET 132
6.6 SMOKE EVACUATION TUBING 135
6.6.1 EASY AVAILABILITY TO SUPPORT MARKET GROWTH 135
6.7 ACCESSORIES 138
6.7.1 ENHANCED EFFICIENCY TO FUEL ADOPTION 138
7 SMOKE EVACUATION SYSTEMS MARKET, BY APPLICATION 141
7.1 INTRODUCTION 142
7.2 LAPAROSCOPIC SURGERIES 143
7.2.1 GROWING ADOPTION OF BARIATRIC SURGERIES TO FUEL MARKET 143
7.3 GENERAL SURGERIES 146
7.3.1 GASTROINTESTINAL SURGERIES 149
7.3.1.1 Increasing number of open surgical procedures to drive market 149
 
7.3.2 GYNECOLOGY SURGERIES 152
7.3.2.1 Lifestyle changes and growing demand for permanent birth control procedures to propel market 152
7.3.3 OTHER GENERAL SURGERIES 155
7.4 ORTHOPEDIC SURGERIES 158
7.4.1 RISING GERIATRIC POPULATION AND INCREASING RISK OF BONE DEGENERATION DISORDERS TO FUEL UPTAKE 158
7.5 MEDICAL AESTHETICS SURGERIES 161
7.5.1 RISING UPTAKE OF LASER SURGERIES TO SUPPORT MARKET GROWTH 161
8 SMOKE EVACUATION SYSTEMS MARKET, BY END USER 164
8.1 INTRODUCTION 165
8.2 HOSPITALS 166
8.2.1 HIGH UPTAKE OF SURGICAL PROCEDURES TO DRIVE MARKET 166
8.3 AMBULATORY SURGERY CENTERS 169
8.3.1 REMOTE CARE AND HIGH EFFICIENCY TO PROPEL MARKET 169
8.4 COSMETIC SURGERY CENTERS 172
8.4.1 GROWING NUMBER OF RECONSTRUCTION PROCEDURES TO FUEL UPTAKE 172
8.5 DENTAL CLINICS 175
8.5.1 INCREASING AWARENESS ABOUT ORAL HEALTH TO SUPPORT MARKET GROWTH 175
8.6 VETERINARY HEALTHCARE PROVIDERS 178
8.6.1 GROWING FOCUS ON IMPROVING AIR QUALITY IN VET SETTINGS TO DRIVE MARKET 178
9 SMOKE EVACUATION SYSTEMS MARKET, BY REGION 181
9.1 INTRODUCTION 182
9.2 NORTH AMERICA 183
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 185
9.2.2 US 190
9.2.2.1 Large volume of surgical procedures in orthopedics and laser treatments to propel market 190
9.2.3 CANADA 195
9.2.3.1 Rising obesity level to expedite growth 195
9.3 EUROPE 200
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 202
9.3.2 GERMANY 208
9.3.2.1 Favorable reimbursement scenario to contribute to growth 208
9.3.3 UK 212
9.3.3.1 Increasing cases of heart and circulatory diseases to promote growth 212
9.3.4 FRANCE 217
9.3.4.1 Increasing adoption of minimally invasive surgical procedures to encourage growth 217
 
9.3.5 ITALY 222
9.3.5.1 Growing adoption of advanced surgical techniques to drive market 222
9.3.6 SPAIN 227
9.3.6.1 Rising prevalence of chronic conditions and aging population to propel market 227
9.3.7 REST OF EUROPE 232
9.4 ASIA PACIFIC 237
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 239
9.4.2 JAPAN 245
9.4.2.1 Decreasing birth rate to support growth 245
9.4.3 CHINA 249
9.4.3.1 Growing proportion of elderly population to boost market 249
9.4.4 INDIA 254
9.4.4.1 Expanding healthcare infrastructure to stimulate growth 254
9.4.5 AUSTRALIA 259
9.4.5.1 Growing cases of chronic and degenerative conditions to fuel market 259
9.4.6 SOUTH KOREA 264
9.4.6.1 Increasing preference for cosmetic surgery to boost market 264
9.4.7 REST OF ASIA PACIFIC 269
9.5 LATIN AMERICA 274
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 274
9.5.2 BRAZIL 280
9.5.2.1 Thriving cosmetic surgery industry to augment growth 280
9.5.3 MEXICO 285
9.5.3.1 High prevalence of obesity to facilitate growth 285
9.5.4 REST OF LATIN AMERICA 290
9.6 MIDDLE EAST & AFRICA 295
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 296
9.6.2 GCC COUNTRIES 302
9.6.2.1 Growing modernization efforts across healthcare industry to drive market 302
9.6.3 REST OF MIDDLE EAST & AFRICA 307
10 COMPETITIVE LANDSCAPE 312
10.1 INTRODUCTION 312
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 312
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SMOKE EVACUATION SYSTEMS MARKET 313
10.3 REVENUE ANALYSIS, 2021–2023 314
10.4 MARKET SHARE ANALYSIS, 2023 314
 
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 316
10.5.1 STARS 316
10.5.2 EMERGING LEADERS 316
10.5.3 PERVASIVE PLAYERS 317
10.5.4 PARTICIPANTS 317
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 318
10.5.5.1 Company footprint 318
10.5.5.2 Product footprint 319
10.5.5.3 Application footprint 320
10.5.5.4 End-user footprint 321
10.5.5.5 Region footprint 322
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 323
10.6.1 PROGRESSIVE COMPANIES 323
10.6.2 RESPONSIVE COMPANIES 323
10.6.3 DYNAMIC COMPANIES 323
10.6.4 STARTING BLOCKS 323
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 325
10.7 BRAND/PRODUCT COMPARISON 327
10.8 R&D ASSESSMENT OF KEY PLAYERS 328
10.9 COMPANY VALUATION & FINANCIAL METRICS 328
10.9.1 FINANCIAL METRICS 328
10.9.2 COMPANY VALUATION 329
10.10 COMPETITIVE SCENARIO 329
10.10.1 PRODUCT APPROVALS 329
10.10.2 DEALS 330
10.10.3 EXPANSIONS 331
11 COMPANY PROFILES 333
11.1 KEY PLAYERS 333
11.1.1 CONMED CORPORATION 333
11.1.1.1 Business overview 333
11.1.1.2 Products offered 334
11.1.1.3 Recent developments 336
11.1.1.3.1 Product approvals 336
11.1.1.4 MnM view 336
11.1.1.4.1 Right to win 336
11.1.1.4.2 Strategic choices 336
11.1.1.4.3 Weaknesses & competitive threats 337
11.1.2 MEDTRONIC 338
11.1.2.1 Business overview 338
11.1.2.2 Products offered 339
11.1.2.3 Recent developments 340
11.1.2.3.1 Product approvals 340
11.1.2.3.2 Expansions 340
11.1.2.4 MnM view 341
11.1.2.4.1 Right to win 341
11.1.2.4.2 Strategic choices 341
11.1.2.4.3 Weaknesses & competitive threats 341
11.1.3 STRYKER 342
11.1.3.1 Business overview 342
11.1.3.2 Products offered 343
11.1.3.3 Recent developments 344
11.1.3.3.1 Product approvals 344
11.1.3.3.2 Expansions 344
11.1.3.4 MnM view 345
11.1.3.4.1 Right to win 345
11.1.3.4.2 Strategic choices 345
11.1.3.4.3 Weaknesses & competitive threats 345
11.1.4 JOHNSON & JOHNSON SERVICES, INC. (ETHICON, INC.) 346
11.1.4.1 Business overview 346
11.1.4.2 Products offered 347
11.1.4.3 MnM view 348
11.1.4.3.1 Right to win 348
11.1.4.3.2 Strategic choices 348
11.1.4.3.3 Weaknesses & competitive threats 349
11.1.5 OLYMPUS CORPORATION 350
11.1.5.1 Business overview 350
11.1.5.2 Products offered 351
11.1.5.3 Recent developments 352
11.1.5.3.1 Deals 352
11.1.5.3.2 Expansions 352
11.1.5.4 MnM view 352
11.1.5.4.1 Right to win 352
11.1.5.4.2 Strategic choices 353
11.1.5.4.3 Weaknesses & competitive threats 353
11.1.6 DANAHER CORPORATION (PALL CORPORATION) 354
11.1.6.1 Business overview 354
11.1.6.2 Products offered 355
11.1.6.3 Recent developments 356
11.1.6.3.1 Deals 356
11.1.7 ECOLAB 357
11.1.7.1 Business overview 357
11.1.7.2 Products offered 358
 
11.1.8 ZIMMER BIOMET 359
11.1.8.1 Business overview 359
11.1.8.2 Products offered 361
11.1.9 THE COOPER COMPANIES, INC. (COOPERSURGICAL INC.) 362
11.1.9.1 Business overview 362
11.1.9.2 Products offered 363
11.1.10 UTAH MEDICAL PRODUCTS, INC. 364
11.1.10.1 Business overview 364
11.1.10.2 Products offered 365
11.1.11 DEROYAL INDUSTRIES, INC. 367
11.1.11.1 Business overview 367
11.1.11.2 Products offered 367
11.1.12 ERBE ELEKTROMEDIZIN GMBH 369
11.1.12.1 Business overview 369
11.1.12.2 Products offered 370
11.1.13 KLS MARTIN GROUP 371
11.1.13.1 Business overview 371
11.1.13.2 Products offered 371
11.1.13.3 Recent developments 372
11.1.13.3.1 Expansions 372
11.1.14 I.C. MEDICAL, INC. 373
11.1.14.1 Business overview 373
11.1.14.2 Products offered 373
11.1.15 ASPEN SURGICAL PRODUCTS, INC. 375
11.1.15.1 Business overview 375
11.1.15.2 Products offered 376
11.1.15.3 Recent developments 376
11.1.15.3.1 Deals 376
11.1.16 BOWA-ELECTRONIC GMBH & CO. KG 377
11.1.16.1 Business overview 377
11.1.16.2 Products offered 377
11.1.16.3 Recent developments 378
11.1.16.3.1 Expansions 378
11.1.17 KARL STORZ 379
11.1.17.1 Business overview 379
11.1.17.2 Products offered 379
11.1.17.3 Recent developments 380
11.1.17.3.1 Deals 380
11.1.17.3.2 Expansions 380
 
11.1.18 SURGIFORM INNOVATIVE SURGICAL PRODUCTS 381
11.1.18.1 Business overview 381
11.1.18.2 Products offered 381
11.1.19 ALESI SURGICAL 382
11.1.19.1 Business overview 382
11.1.19.2 Products offered 382
11.1.19.3 Recent developments 383
11.1.19.3.1 Product approvals 383
11.1.19.3.2 Deals 383
11.1.20 MEYER-HAAKE GMBH 384
11.1.20.1 Business overview 384
11.1.20.2 Products offered 384
11.2 OTHER PLAYERS 385
11.2.1 STERIS 385
11.2.2 CIMPAX A/S 386
11.2.3 CLS SURGIMEDICS 387
11.2.4 ATMOS MEDIZINTECHNIK GMBH & CO. KG 388
11.2.5 WALKER FILTRATION 389
12 APPENDIX 390
12.1 DISCUSSION GUIDE 390
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 394
12.3 CUSTOMIZATION OPTIONS 396
12.4 RELATED REPORTS 396
12.5 AUTHOR DETAILS 397